Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumab

BACKGROUND: Nivolumab is approved for the treatment of refractory metastatic renal cell carcinoma. Patterns and predictors of progressive disease (PD) on nivolumab, and outcomes in such patients are lacking. METHODS: A retrospective analysis of patients (pts) with metastatic clear cell renal cell ca...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Immunother Cancer
Main Authors: Zahoor, Haris, Barata, Pedro C., Jia, Xuefei, Martin, Allison, Allman, Kimberly D., Wood, Laura S., Gilligan, Timothy D., Grivas, Petros, Ornstein, Moshe C., Garcia, Jorge A., Rini, Brian I.
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2018
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6192175/
https://ncbi.nlm.nih.gov/pubmed/30333065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-018-0425-8
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker